Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. CGON
CGON logo

CGON

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CGON News

Royal Caribbean Group Sees Surge in Options Trading Volume

6d agoNASDAQ.COM

CG Oncology Reports FY Earnings with Significant Revenue Growth

Feb 27 2026seekingalpha

CG Oncology Reports 2025 Financial Results and Clinical Progress

Feb 27 2026Newsfilter

CG Oncology Inc. Reports $903 Million in Cash and Marketable Securities to Support Operations Through First Half of 2029

Feb 27 2026moomoo

Wolverine World Wide Sees Surge in Options Trading Volume

Feb 24 2026NASDAQ.COM

Braidwell Reduces Stake in CG Oncology

Feb 19 2026Fool

Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate

Jan 12 2026PRnewswire

Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate

Jan 12 2026Newsfilter

Rich Sparkle Holdings Signs $39 Million Share Offering Agreement

Jan 09 2026Benzinga

CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026

Jan 09 2026Benzinga

CG Oncology Accelerates PIVOT-006 Data Timeline to 1H 2026

Jan 09 2026Globenewswire

Inaugural Week of CGON Options Trading for February 2026

Dec 19 2025NASDAQ.COM

CG Oncology Partners with SUO-CTC to Establish $50,000 NMIBC Research Fellowship

Dec 18 2025Newsfilter

Three Stocks with Significant Growth Potential, According to Top Analysts – 11/27/2025

Nov 27 2025TipRanks

CG Oncology Appoints Christina Rossi to Board of Directors Amid BLA Initiation

Nov 26 2025Newsfilter

CG Oncology Appoints Christina Rossi to Board of Directors Amid BLA Initiation

Nov 26 2025Globenewswire